sun-dragon
INCY Historical Stock Prices ยป
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Incyte is a biopharmaceutical company focused on developing and commercializing proprietary therapeutics. Co.'s portfolio includes compounds in various stages, ranging from preclinical to late stage development, and a commercialized products JAKAFIr (ruxolitinib) and ICLUSIGr (ponatinib). JAKAFI (ruxolitinib) is for the treatment of patients with intermediate or high-risk myelofibrosis and for the treatment of patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. ICLUSIG is a kinase inhibitor targeted for BCR-ABL, an abnormal tyrosine kinase in chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia. According to our Incyte stock split history records, Incyte has had 2 splits.
Incyte stock split history picture
Incyte (INCY) has 2 splits in our Incyte stock split history database. The first split for INCY took place on November 10, 1997. This was a 2 for 1 split, meaning for each share of INCY owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. INCY's second split took place on September 01, 2000. This was a 2 for 1 split, meaning for each share of INCY owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.

When a company such as Incyte splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the Incyte stock split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Incyte shares, starting with a $10,000 purchase of INCY, presented on a split-history-adjusted basis factoring in the complete Incyte stock split history. Incyte split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/04/2008
End date: 02/02/2018
Start price/share: $11.80
End price/share: $85.92
Dividends collected/share: $0.00
Total return: 628.14%
Average Annual Total Return: 21.95%
Starting investment: $10,000.00
Ending investment: $72,787.06
Years: 10.00
Date Ratio
11/10/19972 for 1
09/01/20002 for 1
INCY is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

INFI Split History
INO Split History
INSY Split History
INVA Split History
ISRG Split History
ITUS Split History
IVC Split History
JNJ Split History
JUNO Split History
KALV Split History


More latest
Latest
Latest
Funds Holding Incyte
Incyte Insider Buying